Dimetapp and Aspirin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dimetapp (brompheniramine maleate; phenylpropanolamine hydrochloride) and Aspirin (aspirin). Common drug interactions include pain among females and sinusitis among males.

The phase IV clinical study analyzes what interactions people have when they take Dimetapp and Aspirin. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Dimetapp?

Dimetapp has active ingredients of brompheniramine maleate; phenylpropanolamine hydrochloride. It is often used in cough. eHealthMe is studying from 4,740 Dimetapp users. Check the latest studies of Dimetapp.

What is Aspirin?

Aspirin has active ingredients of aspirin. It is often used in blood clots. eHealthMe is studying from 632,088 Aspirin users. Check the latest studies of Aspirin.



On Jul, 12, 2026

27 people who take Dimetapp and Aspirin together, and have interactions are studied.

Dimetapp and Aspirin drug interactions.

What are the common drug interactions of Dimetapp and Aspirin, by gender? *:

female:

  1. Pain
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Adverse drug reaction
  4. Back pain
  5. Blood creatinine increased
  6. Blood glucose increased
  7. Bradycardia (abnormally slow heart action)
  8. Chills (felling of cold)
  9. Chronic kidney disease
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

male:

  1. Sinusitis (inflammation of sinus)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Gait disturbance
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Nephropathy (damage to or disease of a kidney)
  6. Pain in extremity
  7. Renal failure (kidney dysfunction)
  8. Skin irritation
  9. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  10. Food allergy

What are the common drug interactions of Dimetapp and Aspirin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Drug hypersensitivity
  2. Back pain
  3. Chronic kidney disease
  4. Gait disturbance
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Nephropathy (damage to or disease of a kidney)
  7. Pain in extremity
  8. Renal failure (kidney dysfunction)

50-59:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)

60+:

  1. Pain
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  4. Emotional distress
  5. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  6. Feeling cold
  7. Immunisation reaction
  8. Infection
  9. Injection site erythema (redness at injection site)
  10. Knee arthroplasty

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 10 people, 37.04%
  2. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 3 people, 11.11%
  3. Type 2 Diabetes: 2 people, 7.41%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 7.41%
  5. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 7.41%
  6. Multiple Myeloma (cancer of the plasma cells): 2 people, 7.41%
  7. Infection: 2 people, 7.41%
  8. Hypergammaglobulinaemia (elevated levels of gamma globulin): 2 people, 7.41%
  9. Hiv Infection: 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Dimetapp and Aspirin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dimetapp and Aspirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dimetapp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Aspirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dimetapp and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aspirin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on brompheniramine maleate; phenylpropanolamine hydrochloride and aspirin (the active ingredients of Dimetapp and Aspirin, respectively), and Dimetapp and Aspirin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: